More Stories

Informist, Friday, Nov. 14, 2025

 

Please click here to read all liners published on this story

--Max Health Jul-Sept consol net profit INR 4.91 bln 
--Analysts saw Max Health Jul-Sept consol net profit at INR 4.18 bln 
--Max Health Jul-Sept consol revenue INR 21.35 bln 
--Analysts saw Max Health Jul-Sept consol revenue at INR 25.96 bln 
--Max Health Jul-Sept consol PAT INR 4.91 bln vs INR 2.82 bln year ago 
--Max Health Jul-Sept consol revenue INR 21.35 bln vs INR 17.07 bln year ago 
--Max Health Apr-Sept consol PAT INR 7.99 bln vs INR 5.18 bln year ago 
--Max Health Apr-Sept consol revenue INR 41.63 bln vs INR 32.50 bln year ago 

 

By Anshul Choudhary and Narayana Krishna

 

MUMBAI – Max Healthcare Institute Ltd. reported a sharp on-year rise in consolidated net profit during the September quarter due to a tax write-back. While its net profit growth was better than expected, its revenue missed analysts' estimates.

 

The company reported a consolidated net profit of INR 4.91 billion during the quarter, up 74% on year. Analysts had expected the net profit of INR 4.18 billion, according to the average of estimates from nine brokerages. Its net profit was boosted by a deferred tax write-back of INR 555.60 million. The company's profit before tax during the quarter was up just over 19% on year at INR 4.46 billion.

 

The company's consolidated revenue was INR 21.35 billion, up 25% on year. This was the slowest revenue growth for the company in the last four quarters. Analysts had expected the figure at INR 25.96 billion.

 

On account of the merger of two acquired entities--Crosslay Remedies Ltd. and Jaypee Healthcare Ltd., Max Healthcare reported a tax write-back of INR 1.49 billion for the September quarter. Excluding this one-time impact, the net profit was INR 4.06 billion, up 16% on year, Max Healthcare said.

Besides tax write-backs, the company's net profit for the September was boosted by its operating performance like improvement in occupancy and per bed revenues. The company's September quarter operating margin improved by 30 basis points on year to 26.9%. The average revenue per occupied bed, a key metric in the healthcare industry, improved to INR 77,300 from INR 76,200 a year ago. Earnings before interest, tax, depreciation, and amortisation per bed improved to INR 7.34 million against INR 7.12 million a year ago.

 

The bed occupancy rate for the quarter was at 77%. As on Sept. 30, the overall operational bed capacity of the company touched 4,760. 

The company's diagnostic services arm Max Lab reported a 16% on-year growth for the September quarter to INR 540 million. Max Lab is currently offering its services across 60 cities with over 2,700 tests. Max Home division's revenue was up 20% on year at INR 630 million led by physio-therapy, rehabilitation, and critical care services.

Max Healthcare's consolidated expenses for the quarter were up 25.3% on year at INR 17.2 billon. Finance costs for the quarter rose 60.8% on year to INR 539 million. 

For Apr-Sept, Max Healthcare reported a consolidated net profit of INR 7.99 billion, up 54.3% on year, and revenue for the period was up 28% on year at INR 41.63 billion. On Friday, Max Healthcare's shares ended at INR 1,103.10 on the National Stock Exchange, up 0.5% from Thursday's close.  End

 

Edited by Tanima Banerjee

 

For users of real-time market data terminals, Informist news is available exclusively on the NSE Cogencis WorkStation.

 

Cogencis news is now Informist news. This follows the acquisition of Cogencis Information Services Ltd. by NSE Data & Analytics Ltd., a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt. Ltd.

 

Informist Media Tel +91 (22) 6985-4000

Send comments to feedback@informistmedia.com

 

© Informist Media Pvt. Ltd. 2025. All rights reserved.